Liposaccharide based peptide and vaccine delivery systems: improving the bioavailability and immunogenicity of Luteinizing Hormone-Releasing Hormone

基于脂糖的肽和疫苗递送系统：提高黄体生成激素释放激素的生物利用度和免疫原性

• 批准号: DP110100212
• 负责人: Prof Istvan Toth
• 金额: $ 74.07万
• 依托单位: The University of Queensland
• 依托单位国家: 澳大利亚
• 项目类别: Discovery Projects
• 财政年份: 2011
• 资助国家: 澳大利亚
• 起止时间: 2011-01-01 至 2015-12-31
• 项目状态: 已结题
• 来源: https://dataportal.arc.gov.au/RGS/Web/Grants/DP110100212
• 关键词: Liposaccharide; based; peptide; vaccine; delivery

This project aims to develop new lipid- and sugar-based drug delivery systems for Luteinizing-hormone-releasing hormone (LHRH), a hormone which regulates the level of enzymes involved in fertility conditions and prostate cancers. This technology could be extended to significantly increase the number of drugs available on the market, such as peptide drugs and vaccines.

该项目旨在为促黄体激素释放激素（LHRH）开发新的基于脂质和糖的药物递送系统，LHRH是一种调节与生育条件和前列腺癌有关的酶水平的激素。这项技术可以扩展到显着增加市场上可用的药物数量，如肽药物和疫苗。